SEC bars former rep for alleged share price manipulation

George Thoreson tried to keep penny stock's price high to enable Nasdaq listing.
SEP 18, 2017

The Securities and Exchange Commission has barred George Thoreson, a former broker with Wells Fargo Advisors, for his alleged role in a scheme to manipulate the reported share price and volume of a penny stock. Mr. Thoreson, who lives in the Seattle, Wash., area, was discharged by Wells Fargo in October 2013. He then worked at a registered investment adviser, Northwest Asset Management, from November 2013 to March 2017. He is no longer employed in the securities industry. In its complaint, the SEC alleged that, between approximately April 2012 and September 2013, Mr. Thoreson and others placed trades at above-market prices at or near the end of trading days on several occasions for the purpose of achieving a reported closing price of $2 per share or higher for 90 consecutive trading days, which was a necessary condition for approval of the stock's then-pending Nasdaq listing application. Stock in the company involved in the case, Abakan Inc., recently traded at three-tenths of a cent per share. Mr. Thoreson began his career at Morgan Stanley in 1984 and joined Wells Fargo in 2008.

Latest News

Retirement plan defaults leave key participant decisions unresolved
Retirement plan defaults leave key participant decisions unresolved

New Allspring research finds 401(k) participants want guidance on income and rollovers, not just portfolio automation.

Global equity release market set to triple, with US leading growth
Global equity release market set to triple, with US leading growth

Aging homeowners hold record housing wealth - but most advisors still aren't bringing it into retirement plans

Retiree alleges advisor withheld $600K through real estate LLC web
Retiree alleges advisor withheld $600K through real estate LLC web

$1.7M invested from an inheritance. Then the phone went dead.

SEC accuses Linqto chiefs of 'Wizard of Oz' investor deception
SEC accuses Linqto chiefs of 'Wizard of Oz' investor deception

The pre-IPO platform sold $430M in units while allegedly rigging prices behind the scenes.

GLP-1 users are trading retirement savings for their prescriptions
GLP-1 users are trading retirement savings for their prescriptions

A Nationwide survey finds 47% of GLP-1 users have never discussed the drugs’ financial impact with an advisor, even as many dip into savings.

SPONSORED Built on insurance experience to deliver on long-term promises

Knighthead Life entered the market with a competitive MYGA. A strong launch earned advisor confidence and paved the way for FIAs.

SPONSORED In the Age of AI, Trust Becomes the Advisor's Greatest Asset

As AI makes financial information more accessible than ever, Lana Hock explains why human judgment, trust, and empathy remain the qualities clients value most in a financial advisor